- Synonyms2-amino-3-hydroxy-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoicacid;?-[3,5-Diiodo-4-(3,5-diiodo-4-hydroxyphenoxy)phenyl]serine; Levothyroxine beta-Hydroxy Impurity; Levothyroxine beta-Hydroxy T4 Impurity
- Description
2-amino-3-hydroxy-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoicacid;?-[3,5-Diiodo-4-(3,5-diiodo-4-hydroxyphenoxy)phenyl]serine; Levothyroxine beta-Hydroxy Impurity; Levothyroxine beta-Hydroxy T4 Impurity
Levothyroxine Impurity 21 is a fully characterized chemical compound used as a reference standard of API Levothyroxine. The standard offered is compliant with regulatory guidelines. Levothyroxine Impurity 21 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 107849-54-7
Related products
2-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetic acid

M.F.
M.W. 747.84
CAT# AR-L01604
CAS# NA
4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-benzenemethanol

M.F.
M.W. 719.82
CAT# AR-L13678
CAS# 2055-94-9
alpha-Amino-4-hydroxy-3,5-diiodo-benzeneacetic Acid

M.F.
M.W. 418.96
CAT# AR-T06038
CAS# 854646-83-6